Evolva to enter the Swiss SPI stock index
Based on the rules governing the SPI Index family, only equities with a free float exceeding 20% can be included. Since the partial release of the locked up shares in December 2010, Evolva’s free float complies with this condition. As a consequence, the Index Commission has recommended including Evolva in the SPI index.
Neil Goldsmith, CEO & Managing Director of Evolva, said “Some institutional investors are barred from investing in stocks outside the SPI. Our inclusion in the SPI index reflects our increased free float and broadens our potential investor base. We see this as another positive step in our transition from a private into a broadly owned public company.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.